Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • SALIX PHARMACEUTICALS INC Financial Overview

  • Income Statement: SLXP

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 178.77 M 235.79 M -57.03 M -31.90%
    Gross Profit 125.06 M 170.32 M -45.26 M -36.19%
    Net Income Before Extra Items/Preferred Div -47.04 M 8.22 M -55.26 M 117.49%
    Operating Income -46.66 M 11.85 M -58.51 M 125.40%
  • Cash Flow: SLXP

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 56.62 M 18.08 M 38.54 M 68.07%
    Net Cash Flow - Investing 26.86 M 59.42 M -32.57 M -121.26%
    Net Cash Flow/Operating Activities -20.88 M 76.15 M -97.04 M 464.67%
  • Balance Sheet: SLXP

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 401.15 M 397.10 M 4.04 M 1.01%
    Total Liabilities 150.32 M 104.53 M 45.79 M 30.46%
    Shareholders Equity 250.82 M 292.57 M -41.75 M -16.64%
  • Key Ratios / Statistics: SLXP

    • Valuation

      Price/Earnings (TTM) -9.01
      Price/Sales (TTM) 2.37
      Price/Book (MRQ) 1.99
      Price/Cash Flow (TTM) -40.23
    • Profitability

      Gross Margin 69.96
      Operating Margin -26.10
      Profit Margin -26.31
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 2.22
      Current Ratio (MRQ) 2.28
      Long Term Debt-to-Equity (MRQ) 25.71
    • Management Effectiveness

      Return on Equity (TTM) -17.22
      Return on Assets (TTM) -11.70
      Return on Investments (TTM) -14.63